Access CTD² Results in the Dashboard

* denotes a publication that resulted from CTD²intra-Network collaborations

Funding Opportunity Announcement: NCI is accepting applications for the CTD² Initiative. Visit PAR-21-274 for a high level summary of the goals and details.

Publications

604 Publications Available

Center

July 27, 2021

SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization

Cell Reports

July 20, 2021

Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers

Cell Reports Medicine

June 01, 2021

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation*

Cancer Discovery

May 27, 2021

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages

Cell

May 20, 2021

Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling

Cell Chemical Biology

May 15, 2021

The Panorama of Cancer Genetics

Cancer Res.

May 01, 2021

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

Genome Research

April 01, 2021

Targeting BET proteins BRD2 and BRD3 in combination with PI3K-AKT inhibition as a therapeutic strategy for ovarian clear cell carcinoma

Molecular Cancer Therapeutics

March 04, 2021

An expanded universe of cancer targets*

Cell

March 01, 2021

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype

Journal of Thoracic Oncology

Pages

.